These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clozapine-associated asterixis: case report. Kwak YT; Yang Y; Koo MS J Clin Psychopharmacol; 2014 Feb; 34(1):165-7. PubMed ID: 24158019 [No Abstract] [Full Text] [Related]
4. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia? Jiménez-Cornejo M; Munizaga G; Aceituno D Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589 [TBL] [Abstract][Full Text] [Related]
5. Management of treatment resistant schizophrenia unresponsive to clozapine. Barnes TR; McEvedy CJ; Nelson HE Br J Psychiatry Suppl; 1996 Dec; (31):31-40. PubMed ID: 8968653 [No Abstract] [Full Text] [Related]
6. Clozapine rechallenge in a patient with clozapine-induced hepatitis. Takács A; Sollychin M; Thomas N; Connally F; Pantelis C Australas Psychiatry; 2019 Oct; 27(5):535. PubMed ID: 31545088 [No Abstract] [Full Text] [Related]
8. Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study. Silver H; Kushnir M; Kaplan A Biol Psychiatry; 1996 Oct; 40(7):671-4. PubMed ID: 8886304 [No Abstract] [Full Text] [Related]
9. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report. De Berardis D; Campanella D; Serroni N; Rapini G; Olivieri L; Fornaro M; Valchera A; Iasevoli F; Napoletano C; Martinotti G; Giannantonio MD J Clin Psychopharmacol; 2014 Oct; 34(5):649-51. PubMed ID: 25006818 [No Abstract] [Full Text] [Related]
10. Successful management of clozapine adverse effects with extended (alternate day) antipsychotic dosing in a patient with schizophrenia. Kumar V; Sharma L; Madival S; Venkatasubramanian G J Psychiatry Neurosci; 2016 Jan; 41(1):E1-2. PubMed ID: 26674512 [No Abstract] [Full Text] [Related]
11. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Cook B; Hoogenboom G Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745 [TBL] [Abstract][Full Text] [Related]
12. Clozapine-induced esophagitis at therapeutic dose: a case report. Gonçalves B; Castro J; Zanini MA; Bittencourt L; Gadelha A; Cunha GR; Coelho FM; Tufik S; Bressan RA; Brietzke E Braz J Psychiatry; 2016; 38(2):176-177. PubMed ID: 27304761 [No Abstract] [Full Text] [Related]
13. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol. Bobba R Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119 [No Abstract] [Full Text] [Related]
15. NMS after clozapine initiation. Skarpathiotakis M; Westreich N J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854 [No Abstract] [Full Text] [Related]
16. Effects of clozapine for non-treatment-resistant patients with schizophrenia. Galletly CA; Clark CR; McFarlane AC; Weber DL Psychiatr Serv; 1999 Jan; 50(1):101-3. PubMed ID: 9890589 [TBL] [Abstract][Full Text] [Related]
17. Controls on clozapine must be reviewed. Drew LR Aust N Z J Psychiatry; 2010 May; 44(5):490. PubMed ID: 20397797 [No Abstract] [Full Text] [Related]
18. Successful electroconvulsive therapy and improvement of negative symptoms in refractory schizophrenia with clozapine-induced seizures: a case report. Park S; Lee MK Psychiatr Danub; 2014 Dec; 26(4):360-2. PubMed ID: 25377372 [No Abstract] [Full Text] [Related]
19. Metformin-induced acute dystonia in a schizophrenic patient treated with sulpiride and clozapine. Chen WH; Huang WL; Hsieh MH Psychiatry Clin Neurosci; 2016 Aug; 70(8):362-3. PubMed ID: 27193328 [No Abstract] [Full Text] [Related]
20. Weight Loss During Atomoxetine Add-on to Clozapine-Responsive Schizophrenia. Naguy A; Alamiri B; Khraibut B Am J Ther; 2018; 25(6):e774-e775. PubMed ID: 29782344 [No Abstract] [Full Text] [Related] [Next] [New Search]